Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    74,000

Stocks News & Analysis

stocks

This ASX share just lost its moat

We revisit our long-term earnings assumptions and thesis.
stocks

ASX gold miner overvalued despite stronger gold prices

Higher gold prices boosted profit yet shares remain materially overvalued.
stocks

ASX energy giant undervalued despite commissioning challenges

Near-term hurdles, long-term upside.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,199.7030.700.33%
CAC 408,458.7852.720.63%
DAX 4025,464.01102.980.41%
Dow JONES (US)52,747.32537.241.03%
FTSE 10010,871.0289.270.83%
HKSE25,739.08428.231.69%
NASDAQ24,876.9155.17-0.22%
Nikkei 22561,434.19930.73-1.49%
NZX 50 Index13,976.67114.740.83%
S&P 5007,428.7815.600.21%
S&P/ASX 2009,038.6035.100.39%
SSE Composite Index3,831.5518.230.48%

Market Movers